ChAdOx1 nCoV-19 is a potential vaccine for the coronavirus. Early results from trials show that the vaccine is safe and produces an immune response against the virus that causes COVID-19. Another name for ChAdOx1 nCoV-19 is AZD1222, used especially in the context of the vaccine’s co-development by the University of Oxford, Vaccitech, and AstraZeneca. ChAdOx1 nCoV-19 is especially used in the context of Oxford’s leading role in first developing the vaccine.
explainza.com | 🔎
Our projects: Financial Independence: Your personal finances in the cloud | CatamaranAdvisor: Catamaran database, catamaran specifications, photos of catamaran interiors and exteriors